Should I Buy Laboratory Corporation of America Holdings Stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. LH has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
LH stock price ended at $242.53 on Friday, after rising0.26%
The Laboratory Corporation of America Holdings stock price increased by 0.26% on the last trading day (23 May 2025), rising from 240.73 to 242.53. Throughout the last trading session, the stock experienced a fluctuation of 1.27% , ranging from a day low of $239.75 to a day high of 242.8. The price has declined in 3 of the last 10 days, resulting in a total change of -1.30% during this period. On the last day, trading volume increase by -92.65K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 503.83K shares were traded, amounting to approximately 121.98M.
LH Technical Signals
LH(Laboratory Corporation of America Holdings Corp) has 4 buy signals and 1 sell signal now. The current trend is consolidation starting from 2025-05-20. The total price change during this trend is -3.30%. Recently, the price has increased but the volume has decreased, indicating a potential warning signal. The average turnover of LH over the last 5 trading days is 166.45M. Overall, the technical indicator signals lean more toward a Bullish outlook in the mid-term.
LH Moving Average Analysis
Laboratory Corporation of America Holdings's overall moving average trend leans more bullish as of Saturday, May 24, 2025, with 1 negative signals and 3 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $253.54006, and $258.189. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $238.49794, and $233.849. A break-down below any of these levels will issue sell signals.
LH Short Selling Analysis
The short sale ratio of Laboratory Corporation of America Holdings(LH) as of 16 May 2025 is 24.23%, dropping from last trading day. With decreasing price from 246.27 to 249.52. The short sell activity indicate that short sellers may be experiencing short cover.
Technical Signal
Technical Signals Summary
Sell
1
Buy
4
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Positive
SMA_20 Above SMA_60
Long Term
Positive
SMA_60 Above SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
4 Bullish Signals
4 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 < 20
17.294
Bullish
Awesome Oscillator (5, 34)
AO_5_34 > 0
10.315
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
2.999
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
4.203
Bullish
1 Bearish Signals
1 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Momentum (10 days)
MOM_10 < 0
-3.2
Bearish
LH Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Laboratory Corporation of America Holdings(LH), our algorithm predicts LH's 1-month price at $229.43, with an -8.05%downwardshift. Using a similarity score up to 97.28%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Laboratory Corporation of America Holdings (LH.N) stock, as of Sunday, May 18, 2025 , forecasts a -8.05% change over the next month, based on its high correlation with SLF.N stock patterns. The similarity between their price movements over the analyzed periods is 97.28%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
LH
No Data
SLF
Down: -8.05%Similarity: 97.28%
Name
Similarity
Up/Down
SLF.N
97.28%
-8.05%
AA.N
96.89%
+22.50%
TRP.N
96.87%
+4.18%
GOLF.N
96.85%
-1.78%
LFUS.O
96.73%
-6.41%
DOX.O
96.65%
-0.02%
CYBR.O
96.63%
+1.48%
PNC.N
96.63%
-6.67%
BHC.N
96.56%
+0.82%
BLK.N
96.55%
-1.45%
LH Seasonality Analysis
Based on LH's historical stock price data across all years, the probability of a positive return in May is63.64%, suggesting it maybe an ideal month to invest in LH. In contrast,Julyoffers the highest probability of positive returns at80.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Laboratory Corporation of America Holdings (LH.N) stock in July has the highest probability of a positive return (80.00%), while August has the lowest probability (30.00%).
Performance Seasonality
The chart shows Laboratory Corporation of America Holdings. (LH)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Laboratory Corporation of America Holdings (LH.N) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. LH has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying Laboratory Corporation of America Holdings (LH.N) stock in a year?
The radar chart shows that buying Laboratory Corporation of America Holdings (LH.N) stock in July has the highest probability of a positive return (80.00%), while August has the lowest probability (30.00%).
How has Laboratory Corporation of America Holdings. (LH)'s stock price performed over the past three years?
LH's stock price rose by 12.72% in 2023,decreased by -0.39% in 2024, and went up by 6.28% in 2025.
Bearish technical signals of LH include: MOM_10 < 0.
Is LH a buy based on overall technical signals summary?
LH has 4 buy signals and 1 sell signals now. Overall the technical rating for LH is Buy . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of LH.
What is the trend of Laboratory Corporation of America Holdings (LH)'s moving average?
Laboratory Corporation of America Holdings's overall moving average trend leans more bullish as of May 24 2025, with 1 negative signals and 3 positive signal.
What is price prediction for LH stock next month?
The price prediction chart for Laboratory Corporation of America Holdings (LH.N) stock, as of May 18 2025, forecasts a -8.05% change over the next month, based on its high correlation with SLF stock patterns. The similarity between their price movements over the analyzed periods is 97.28%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for LH Stock?
The price prediction for LH stock in 2025 is approximately **$280 per share**, driven by strong earnings growth and positive analyst sentiment. The stock is expected to benefit from its solid financial performance and favorable industry trends.
What is price prediction 2030 for LH Stock?
The price prediction for LH stock by 2030 is approximately **$290 per share**. This forecast is based on strong revenue growth, expansion into high-margin services like oncology and women's health, and positive analyst sentiment with a current average 12-month target of $276.00.